Growth Metrics

Insulet (PODD) Shareholder's Equity Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -2.10%
Dec 31, 2025 25.06%
Sep 30, 2025 23.80%
Jun 30, 2025 46.52%
Mar 31, 2025 68.28%
Dec 31, 2024 65.36%
Sep 30, 2024 84.03%
Jun 30, 2024 80.25%
Mar 31, 2024 57.26%
Dec 31, 2023 53.80%
Sep 30, 2023 41.94%
Jun 30, 2023 31.13%
Mar 31, 2023 12.56%
Dec 31, 2022 -14.36%
Sep 30, 2022 -14.04%
Jun 30, 2022 -7.99%
Mar 31, 2022 -23.68%
Dec 31, 2021 -7.84%
Sep 30, 2021 -16.32%
Jun 30, 2021 -18.50%
Mar 31, 2021 892.03%
Dec 31, 2020 695.26%
Sep 30, 2020 295.09%
Jun 30, 2020 125.50%
Mar 31, 2020 -73.61%
Dec 31, 2019 -64.21%
Sep 30, 2019 -23.91%
Jun 30, 2019 39.44%
Mar 31, 2019 31.09%
Dec 31, 2018 33.82%
Sep 30, 2018 166.56%
Jun 30, 2018 176.78%
Mar 31, 2018 168.25%
Dec 31, 2017 151.19%
Sep 30, 2017 14.07%
Jun 30, 2017 135.84%
Mar 31, 2017 140.89%
Dec 31, 2016 85.31%
Sep 30, 2016 18.07%
Jun 30, 2016 -60.94%
Mar 31, 2016 -67.31%
Dec 31, 2015 -59.38%
Sep 30, 2015 -31.38%
Jun 30, 2015 -9.80%
Mar 31, 2015 -34.08%
Dec 31, 2014 -32.72%
Sep 30, 2014 -33.84%
Jun 30, 2014 -43.70%
Mar 31, 2014 -5.45%
Dec 31, 2013 182.05%
Sep 30, 2013 140.68%
Jun 30, 2013 134.11%
Mar 31, 2013 84.50%
Dec 31, 2012 -46.61%
Sep 30, 2012 -46.77%
Jun 30, 2012 -43.96%
Dec 31, 2011 24.92%